Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

20.79 -0.78 (-3.62%)
Official Closing Price Updated: 7:00 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,721,519
Open 21.31
Bid (Size) 20.68 (1)
Ask (Size) 20.81 (2)
Prev. Close 21.57
Today's Range 20.70 - 21.95
52wk Range 5.650 - 21.95
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking Into Hims & Hers Health's Recent Short Interest
Via Benzinga
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In May: Where Do Nvidia, Tesla, GameStop, AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga

Performance

YTD
+115.66%
+115.66%
1 Month
+71.11%
+71.11%
3 Month
+45.79%
+45.79%
6 Month
+140.62%
+140.62%
1 Year
+136.25%
+136.25%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Kimberly-Clark To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Looking At Hims & Hers Health's Recent Unusual Options Activity
Via Benzinga
Smart Money Is Betting Big In HIMS Options
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Via Benzinga
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Via MarketBeat
Hims & Hers Health Stock Soared This Week: Here's Why
Via The Motley Fool
SPDR ETF Report For Thursday, May 30
Via Talk Markets
Topics ETFs
Call Option Volumes Spiked For These 3 Stocks
Via MarketBeat
Navigating 10 Analyst Ratings For Hims & Hers Health
Via Benzinga
Hims & Hers Is Changing the Game
Via The Motley Fool
SPDR ETF Report For Wednesday, May 29
Via Talk Markets
Topics ETFs
SPDR ETF Report For Tuesday, May 28
Via Talk Markets
Topics ETFs
A New Name in Weight Loss Drugs
Via The Motley Fool
LifeMD Can Surge on Its GLP-1 Offerings
Via MarketBeat
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
Via The Motley Fool
The Ultimate Growth Stock to Buy With $20 Right Now
Via The Motley Fool
7 Stocks to Dominate in the Next Economic Upturn
Via InvestorPlace
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
Via InvestorPlace
The Growth Stock Shuffle: 2 to Ditch and 1 to Own
Via InvestorPlace
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Via Benzinga
Topics ETFs
Meme Stocks GameStop, AMC Fade In Interest After Roaring Kitty Exit: Here's What WallStreetBets Is Eyeing Next
Via Benzinga
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.